C<\/b>ategor\u00eda<\/p>\n<\/td>\n
Criterios de Filtrado Glomerular (FG)<\/p>\n<\/td>\n
Criterios de Flujo Urinario (FU)<\/p>\n<\/td>\n
R<\/b>iesgo<\/p>\n<\/td>\n
Creatinina incrementada x1,5 o FG disminuido > 25%<\/p>\n<\/td>\n
FU < 0,5ml\/kg\/h x 6 hr<\/p>\n<\/td>\n
Alta Sensibilidad<\/p>\n
Alta Especificidad<\/p>\n<\/td>\n<\/tr>\n
I<\/b>njuria<\/p>\n<\/td>\n
Creatinina incrementada x2 o FG disminuido > 50% <\/p>\n<\/td>\n
FU < 0,5ml\/kg\/h x 12 hr<\/p>\n<\/td>\n<\/tr>\n
F<\/b>allo<\/p>\n<\/td>\n
Creatinina incrementada x3 o FG disminuido > 75%<\/p>\n<\/td>\n
FU < 0,3ml\/kg\/h x 24 hr o Anuria x 12 hrs<\/p>\n<\/td>\n<\/tr>\n
L<\/b>oss (P\u00e9rdida)<\/p>\n<\/td>\n
IRA persistente = completa p\u00e9rdida de la funci\u00f3n renal > 4 semanas<\/p>\n<\/td>\n
E<\/b>SKD (IRC)<\/p>\n<\/td>\n
Insuficiencia Renal Estadio Terminal (> 3 meses) <\/p>\n<\/td>\n
FG: Filtrado Glomerular<\/p>\n
IRA: Insuficiencia Renal Aguda<\/p>\n
ESKD (End Stage Kidney Disease): IRC (Insuficiencia Renal Estadio Terminal)<\/p>\n
Fuente: Bellomo R, Kellum JA, Mehta R, Palevsky PM, Ronco C. Acute Dialysis Quality Initiative II: the Vicenza conference. Curr Opin Crit Care. 2002 Dec;8(6):505-8.<\/p>\n
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004 Aug;8(4):R204-12. Epub 2004 May 24<\/p>\n
<\/div>\n","protected":false},"excerpt":{"rendered":"\u00a0 Categor\u00eda Criterios de Filtrado Glomerular (FG) Criterios de Flujo Urinario (FU) Riesgo Creatinina incrementada x1,5 o FG disminuido > 25% FU < 0,5ml\/kg\/h x 6 hr Alta Sensibilidad Alta Especificidad Injuria Creatinina incrementada x2 o FG disminuido > 50% FU < 0,5ml\/kg\/h x 12 hr Fallo Creatinina incrementada x3 o FG disminuido > 75% … Continue reading “Criterios RIFLE para Insuficiencia Renal Aguda (IRA).”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-1967","post","type-post","status-publish","format-standard","hentry","category-nefrologia"],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/posts\/1967","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1967"}],"version-history":[{"count":0,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=\/wp\/v2\/posts\/1967\/revisions"}],"wp:attachment":[{"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1967"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1967"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicinainterna.com.mx\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1967"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}